Baverez, C.; Grall, M.; Gerfaud-Valentin, M.; De Gail, S.; Belot, A.; Perpoint, T.; Weber, E.; Reynaud, Q.; Sève, P.; Jamilloux, Y.
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases. J. Clin. Med. 2022, 11, 5799.
https://doi.org/10.3390/jcm11195799
AMA Style
Baverez C, Grall M, Gerfaud-Valentin M, De Gail S, Belot A, Perpoint T, Weber E, Reynaud Q, Sève P, Jamilloux Y.
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases. Journal of Clinical Medicine. 2022; 11(19):5799.
https://doi.org/10.3390/jcm11195799
Chicago/Turabian Style
Baverez, Clara, Maximilien Grall, Mathieu Gerfaud-Valentin, Sarah De Gail, Alexandre Belot, Thomas Perpoint, Emmanuelle Weber, Quitterie Reynaud, Pascal Sève, and Yvan Jamilloux.
2022. "Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases" Journal of Clinical Medicine 11, no. 19: 5799.
https://doi.org/10.3390/jcm11195799
APA Style
Baverez, C., Grall, M., Gerfaud-Valentin, M., De Gail, S., Belot, A., Perpoint, T., Weber, E., Reynaud, Q., Sève, P., & Jamilloux, Y.
(2022). Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases. Journal of Clinical Medicine, 11(19), 5799.
https://doi.org/10.3390/jcm11195799